Use of Cyclophosphamide/Fludarabine to Promote in Vivo Expansion of Donor Lymphocyte Infusions (DLI) to Enhance Efficacy After Allogeneic Transplant.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Fludarabine
- Indications Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies
- Focus Therapeutic Use
- 30 Jul 2019 Biomarkers information updated
- 28 Jun 2011 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.
- 28 Jun 2011 Planned end date changed from 1 Dec 2012 to 1 Dec 2014 as reported by ClinicalTrials.gov.